The Garvan Institute of Medical Research brings together world-leading researchers and clinicians, collaborating locally and globally, to advance our understanding of disease, particularly cancer, immune diseases and genetic disorders.

We see a future where all diseases can be prevented, treated or cured. Building on our scientific strengths in genomics, cancer and immunology, enabled by cutting-edge technology and world-class facilities, we will drive more of our discoveries to clinical and societal impact.

Founded in 1963, Garvan’s researchers have made transformative breakthroughs for diseases such as rare cancers, cancers of the breast, prostate and pancreas, immune deficiency, autoimmunity and COVID-19. Today, Garvan’s mission builds on those advances to drive extraordinary science with transformational impact for health.

Patients, clinical trials and diverse population cohorts are central to Garvan’s work. We are focused on addressing the unmet needs of those living with disease, where better understanding, new treatments and more effective diagnosis can have the biggest impact for individuals and their families.